Geriatric Medicine Market is estimated to increase at a growth rate of 7.3% CAGR over the forecast period from 2024 to 2030.
The Geriatric Medicine Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Therapeutics (Analgesic, Antihypertensive, Statins, Antidiabetic, PPI, Anticoagulant, Antipsychotic, Others), By Condition (Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory , Others).
An Introduction to Geriatric Medicine Market in 2024
The Geriatric Medicine market in 2024 serves the demand for healthcare services, medications, and interventions tailored to the unique needs and challenges of elderly patients, addressing age-related health conditions, chronic diseases, and geriatric syndromes such as frailty, cognitive impairment, and polypharmacy. Geriatric medicine encompasses a multidisciplinary approach to healthcare delivery, including comprehensive geriatric assessments, medication management, fall prevention programs, rehabilitation services, and palliative care for older adults with complex medical and social needs. Market dynamics are driven by factors such as demographic trends, population aging, the increasing prevalence of chronic diseases in older populations, and the demand for specialized geriatric care models and gerontology training programs for healthcare professionals. Collaboration between geriatricians, primary care physicians, nurses, and allied health professionals drives innovation and market growth in geriatric medicine, supporting improved health outcomes, functional independence, and quality of life for older individuals as they age.
Geriatric Medicine Market Trend: Rise in Geriatric Population and Age-Related Health Challenges
A prominent trend in the geriatric medicine market is the rise in the geriatric population and age-related health challenges. With advancements in healthcare leading to increased life expectancy, the global population is aging rapidly, resulting in a growing number of older adults who require specialized medical care to address age-related health conditions and chronic diseases. Geriatric medicine focuses on the unique healthcare needs of older adults, including managing chronic conditions, preventing functional decline, and promoting healthy aging. This trend is fueled by demographic shifts, changing disease patterns, and the need for comprehensive geriatric assessment and multidisciplinary care to optimize health outcomes and quality of life for older individuals.
Geriatric Medicine Market Driver: Increasing Burden of Chronic Diseases and Multimorbidity in Older Adults
A key driver in the geriatric medicine market is the increasing burden of chronic diseases and multimorbidity among older adults. Chronic diseases such as hypertension, diabetes, heart disease, arthritis, and dementia are highly prevalent in the geriatric population, often coexisting and contributing to functional impairment, disability, and reduced quality of life. Managing multimorbidity and complex medical conditions in older adults requires specialized expertise in geriatric medicine, comprehensive care coordination, and personalized treatment plans tailored to individual patient needs and preferences. This driver is supported by factors such as population aging, unhealthy lifestyle behaviors, and healthcare system challenges in providing coordinated and integrated care for older adults, driving demand for geriatricians, geriatric specialists, and interdisciplinary geriatric care teams.
Geriatric Medicine Market Opportunity: Development of Age-Specific Therapeutics and Geriatric Care Models
An opportunity for growth in the geriatric medicine market lies in the development of age-specific therapeutics and geriatric care models. As the geriatric population continues to grow, there is a need for tailored medical interventions and care approaches that address the unique physiological, cognitive, and psychosocial needs of older adults. Pharmaceutical companies can capitalize on opportunities to develop medications with dosing regimens, formulations, and safety profiles optimized for older patients, considering age-related changes in drug metabolism, pharmacokinetics, and drug-drug interactions. Additionally, there is potential to innovate in geriatric care delivery models, such as home-based care, telemedicine, interdisciplinary geriatric clinics, and transitional care programs, to provide holistic and patient-centered care for older adults across care settings. By investing in age-specific therapeutics and geriatric care models, healthcare organizations and pharmaceutical companies can improve health outcomes, enhance patient satisfaction, and address the growing demand for high-quality geriatric care in an aging population.
Geriatric Medicine Market Segmentation
By Therapeutics
Analgesic
Antihypertensive
Statins
Antidiabetic
PPI
Anticoagulant
Antipsychotic
Others
By Condition
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Geriatric Medicine Market Companies
Abbott Laboratories Inc
AbbVie (Allergan Inc)
AstraZeneca PLC
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Endo Pharmaceuticals Inc
F. Hoffmann-La Roche AG
Merck & Co. Inc
Novartis AG
Octapharma AG
Pfizer Inc
Regeneron Pharmaceuticals Inc
Sanofi SA
Reasons to Buy the Geriatric Medicine Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Geriatric Medicine Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Geriatric Medicine Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Geriatric Medicine Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Geriatric Medicine Market Size Outlook, $ Million, 2021 to 2030
3.2 Geriatric Medicine Market Outlook by Type, $ Million, 2021 to 2030
3.3 Geriatric Medicine Market Outlook by Product, $ Million, 2021 to 2030
3.4 Geriatric Medicine Market Outlook by Application, $ Million, 2021 to 2030
3.5 Geriatric Medicine Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Geriatric Medicine Market Industry
4.2 Key Market Trends in Geriatric Medicine Market Industry
4.3 Potential Opportunities in Geriatric Medicine Market Industry
4.4 Key Challenges in Geriatric Medicine Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Geriatric Medicine Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Geriatric Medicine Market Outlook By Segments
7.1 Geriatric Medicine Market Outlook by Segments
By Therapeutics
Analgesic
Antihypertensive
Statins
Antidiabetic
PPI
Anticoagulant
Antipsychotic
Others
By Condition
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Others
8 North America Geriatric Medicine Market Analysis And Outlook To 2030
8.1 Introduction to North America Geriatric Medicine Markets in 2024
8.2 North America Geriatric Medicine Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Geriatric Medicine Market size Outlook by Segments, 2021-2030
By Therapeutics
Analgesic
Antihypertensive
Statins
Antidiabetic
PPI
Anticoagulant
Antipsychotic
Others
By Condition
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Others
9 Europe Geriatric Medicine Market Analysis And Outlook To 2030
9.1 Introduction to Europe Geriatric Medicine Markets in 2024
9.2 Europe Geriatric Medicine Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Geriatric Medicine Market Size Outlook By Segments, 2021-2030
By Therapeutics
Analgesic
Antihypertensive
Statins
Antidiabetic
PPI
Anticoagulant
Antipsychotic
Others
By Condition
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Others
10 Asia Pacific Geriatric Medicine Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Geriatric Medicine Markets in 2024
10.2 Asia Pacific Geriatric Medicine Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Geriatric Medicine Market size Outlook by Segments, 2021-2030
By Therapeutics
Analgesic
Antihypertensive
Statins
Antidiabetic
PPI
Anticoagulant
Antipsychotic
Others
By Condition
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Others
11 South America Geriatric Medicine Market Analysis And Outlook To 2030
11.1 Introduction to South America Geriatric Medicine Markets in 2024
11.2 South America Geriatric Medicine Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Geriatric Medicine Market size Outlook by Segments, 2021-2030
By Therapeutics
Analgesic
Antihypertensive
Statins
Antidiabetic
PPI
Anticoagulant
Antipsychotic
Others
By Condition
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Others
12 Middle East And Africa Geriatric Medicine Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Geriatric Medicine Markets in 2024
12.2 Middle East and Africa Geriatric Medicine Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Geriatric Medicine Market size Outlook by Segments, 2021-2030
By Therapeutics
Analgesic
Antihypertensive
Statins
Antidiabetic
PPI
Anticoagulant
Antipsychotic
Others
By Condition
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories Inc
AbbVie (Allergan Inc)
AstraZeneca PLC
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Endo Pharmaceuticals Inc
F. Hoffmann-La Roche AG
Merck & Co. Inc
Novartis AG
Octapharma AG
Pfizer Inc
Regeneron Pharmaceuticals Inc
Sanofi SA
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
